Neoleukin Therapeutics, Inc

NLTX NASDAQ

NAK1987

Analyst buy rating with good technical signs for long entry with tight stop , also inside buying if merit today . entry 12.38 stop 11.97 adjust stop daily with ideal profit around $14.

rivchris

NLTX - I know nothing about this stock other than it has the most obvious inverse H&S i've seen. Each shoulder is a iH&S on it's own.

therealrogi

13.43 is next major resistance (local high) to overcome, then targeting 16. Support for idea +breakout ascending triangle (12 resistance) +local support/resistance (12.00, 13.43, 16.00) +wave 3 wyckoff (8>12 | 12>10 | 10>+) +inverse head-and-shoulders

EcoTrader-tv

Hi, today we are going to talk about Neoleukin Therapeutics and its current landscape. Neoleukin Therapeutics company receives attention today as the Cancer - Drug Race heats up, in the middle a day of the announcements of a $5.2 billion total in Acquisitions by big names of the pharmaceuticals sector, such as Merck & Co. and Sanofi, that had made strategic...

PennyStock101

Neoleukin Therapeutics, Inc., formerly Aquinox Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is focused on the development and commercialization of computationally-designed protein therapeutics to address unmet medical needs in immuno-oncology, inflammation, and autoimmunity. Its computational platform allows it to design new de novo proteins...